We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Combined Laser and Nanotube Therapy Destroys Kidney Tumors

By HospiMedica International staff writers
Posted on 14 Aug 2009
A novel cancer treatment has been described that is based on carbon nanotubes that heat up when exposed to laser light and then destroy tumors into which they have been injected.

Investigators from Wake Forest University (Winston Salem, NC, USA) evaluated several protocols that involved injection of multiwalled carbon nanotubes (MWCNTs) directly into kidney tumors in a population of laboratory mice. More...
After injection of the nanotubes, the area of the tumors was subjected to various levels of laser light for different periods.

Data published in the July 20, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) revealed that injection of 100 micrograms of MWCNT followed by illumination for 30 seconds with a low power (three-watt) laser resulted in complete ablation of tumors and a more than nine month period of lasting remission in 80% of the mice. In contrast, mice that received no treatment, mice that received nanotubes with no laser treatment, and mice that received laser treatment without nanotubes died about 30 days into the study. The treatment caused minimal local toxicity with no evidence of systemic toxicity.

"You can actually watch the tumors shrinking until, one day, they are gone,” said senior author Dr. Suzy Torti, professor of biochemistry at Wake Forest University. "Not only did the mice survive, but they maintained their weight, did not have any noticeable behavioral abnormalities and experienced no obvious problems with internal tissues. As far as we can tell, other than a transient burn on the skin that did not seem to affect the animals and eventually went away, there were no real downsides--that is very encouraging. When dealing with cancer, survival is the endpoint that you are searching for. It is great if you can get the tumor to shrink, but the gold standard is to make the tumor shrink or disappear and not come back. It appears that we have found a way to do that.”

Related Links:
Wake Forest University



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.